HYPERLIPIDEMIA
Clinical trials for HYPERLIPIDEMIA explained in plain language.
Never miss a new study
Get alerted when new HYPERLIPIDEMIA trials appear
Sign up with your email to follow new studies for HYPERLIPIDEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Home cholesterol checks beat standard care in small trial
Disease control CompletedThis study tested whether people with high cholesterol who check their own levels at home and get phone support can lower their LDL more than those getting standard care. 70 adults with LDL over 130 mg/dL took part. The idea was that frequent self-testing would help them stick to…
Matched conditions: HYPERLIPIDEMIA
Phase: PHASE4 • Sponsor: Temple University • Aim: Disease control
Last updated May 17, 2026 02:01 UTC
-
New shot could tame stubborn high cholesterol
Disease control CompletedThis study tested a new medicine called SHR-1918, given as multiple shots under the skin, in 44 adults with high cholesterol that was not well controlled by current treatments. The goal was to see if it safely lowers 'bad' LDL cholesterol over 24 weeks. This is a phase 2 trial, m…
Matched conditions: HYPERLIPIDEMIA
Phase: PHASE2 • Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New cholesterol drug HRS-1301 passes early safety check in 82 healthy people
Disease control CompletedThis early-stage study tested a new drug called HRS-1301 in 82 healthy adults to see if it is safe and how the body processes it. The goal is to eventually use it to control high cholesterol, which is a risk factor for heart disease. Participants took single or multiple doses, an…
Matched conditions: HYPERLIPIDEMIA
Phase: PHASE1 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated May 14, 2026 12:01 UTC
-
New injection HRS-7249 tested for high cholesterol in first human study
Disease control CompletedThis early-stage study tested a single injection of HRS-7249 in 32 to 48 healthy adults with mildly to moderately high cholesterol. The main goal was to check safety and how the drug moves through the body. Participants received either the drug or a placebo, and researchers monit…
Matched conditions: HYPERLIPIDEMIA
Phase: PHASE1 • Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
HIV cholesterol showdown: which statin works best?
Disease control CompletedThis study tested two statins, rosuvastatin and pravastatin, in 86 people with HIV who had high cholesterol and were taking antiretroviral drugs. The goal was to see which drug lowers LDL (bad) cholesterol more safely and effectively over 45 days. Results help doctors choose the …
Matched conditions: HYPERLIPIDEMIA
Phase: PHASE4 • Sponsor: French National Agency for Research on AIDS and Viral Hepatitis • Aim: Disease control
Last updated May 11, 2026 20:52 UTC
-
Heart pill showdown: one combo pill vs. two separate pills – which works better?
Knowledge-focused CompletedThis study tested a new single pill that combines two common heart medications (pitavastatin and valsartan) against taking them separately. 52 healthy men participated to see how the drugs are absorbed and processed by the body. The goal was to find out if the combination pill wo…
Matched conditions: HYPERLIPIDEMIA
Phase: PHASE1 • Sponsor: JW Pharmaceutical • Aim: Knowledge-focused
Last updated May 17, 2026 02:06 UTC
-
Aspirin vs. niacin flush: tiny study seeks answers
Knowledge-focused CompletedThis small study looked at whether taking aspirin before niacin can reduce the uncomfortable flushing (redness and warmth) that niacin often causes. Nine healthy adults with high cholesterol took either aspirin or a placebo for five days, then a single dose of niacin. Researchers…
Matched conditions: HYPERLIPIDEMIA
Phase: NA • Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated May 17, 2026 02:03 UTC
-
Healthy volunteers help test new drug interaction with cholesterol medication
Knowledge-focused CompletedThis study looked at how a new drug, HRS-1301, changes the way the body processes a common cholesterol-lowering medicine (rosuvastatin). Sixteen healthy adults took both drugs in a fixed order, and researchers measured drug levels in the blood. The goal was to gather safety and i…
Matched conditions: HYPERLIPIDEMIA
Phase: PHASE1 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Knowledge-focused
Last updated May 17, 2026 02:02 UTC
-
Fat processing test may predict heart attack risk
Knowledge-focused CompletedThis study looked at how well people with stable coronary artery disease handle fats (triglycerides) and sugar after a meal. Over 18 months, researchers tracked heart attacks, strokes, and deaths to see if a fat-tolerance test could identify those at higher risk. The goal was to …
Matched conditions: HYPERLIPIDEMIA
Sponsor: Universität des Saarlandes • Aim: Knowledge-focused
Last updated May 13, 2026 15:58 UTC
-
Scientists study blood fats to uncover heart disease clues
Knowledge-focused CompletedThis study looked at how fat particles called lipoproteins travel in the blood and how they relate to artery hardening. Researchers studied 759 people, including healthy volunteers and those with high cholesterol or other lipid disorders. Participants received injections of label…
Matched conditions: HYPERLIPIDEMIA
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated May 11, 2026 20:49 UTC